The Journal of clinical psychiatry
-
Randomized Controlled Trial Multicenter Study Comparative Study
A double-blind, randomized controlled clinical trial comparing eicosapentaenoic acid versus docosahexaenoic acid for depression.
To compare 2 omega-3 (n-3) preparations enriched with eicosapentaenoic acid (EPA) versus docosahexaenoic acid (DHA) as monotherapy for major depressive disorder (MDD) in a 2-site, placebo-controlled, randomized, double-blind clinical trial. ⋯ Neither EPA-enriched nor DHA-enriched n-3 was superior to placebo for the treatment of MDD.